Congress mandates hospitals ignore vaccination in organ transplant decisions
H.R. 2015 — GIFT Act of 2025 · Filed by W. Steube (R-FL) · Introduced Mar 10, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill amends Medicare hospital participation rules to prohibit hospitals from considering a patient's vaccination status when deciding who receives an organ transplant. It adds a new requirement to Section 1866(a)(1) of the Social Security Act, making vaccination status irrelevant to organ allocation decisions for Medicare-participating hospitals.
Why we flagged it
The bill is a straightforward legislative mandate removing one medical criterion from organ transplant allocation decisions. It does not create a new program or subsidy; it restricts hospital discretion in a specific medical context.
What the text implies
- The bill does not specify how hospitals should allocate organs if vaccination status is removed — it leaves existing allocation protocols (UNOS guidelines, medical urgency, tissue matching, time on waitlist) in place but removes one factor. Hospitals may face legal uncertainty about whether other health factors correlated with vaccination (e.g., immunosuppression, comorbidities) remain permissible
- Organ allocation is governed by the Organ Procurement and Transplantation Network (OPTN) under federal contract; this bill may create tension between Medicare participation requirements and OPTN medical standards if they diverge on vaccination relevance.
The full analysis lists 3 implications of this text.
Who it affects
The bill removes one allocation criterion, which may benefit unvaccinated patients who would otherwise be deprioritized, but organ allocation is medically complex and evidence-based. Removing vaccination status as a permissible factor could harm patients whose medical outcomes depend on vaccination status (e.g., immunocompromised recipients, post-transplant survival rates), and may conflict with medical best practices established by transplant societies.